Hepatitis C virus in hemodialysis patients.
Anti-HCV prevalence in 284 hemodialysis patients was assessed using the Abbott HCV-EIA test. Anti-HCV positivity was found in 19.4% of patients, was higher in males than in females and progressively increased with age. A correlation between time of dialysis treatment, transfusions and ALT course was found. These data suggest that HCV infection is a very important risk in dialysis units.
Dentico
P
P
Istituto Policattedra Clinica Medica e Malattie Infettive, Università di Bari, Italy.
Volpe
A
A
Buongiorno
R
R
Carlone
A
A
Carbone
M
M
Manno
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D003428:Cross Infection / Q000201:enzymology / Q000276:immunology / Q000635:transmission; D005260:Female; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000201:enzymology / Q000276:immunology / Q000635:transmission; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D065227:Transfusion Reaction
D006508:Hepatitis Antibodies; D000410:Alanine Transaminase